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Arterial Stiffness Is Associated With Cytomegalovirus-Speciﬁc
Senescent CD8+ T Cells
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Background-—Arterial stiffness is a well-known predictor of future cardiovascular events. Search for the underlying mechanism of
arterial stiffening is still under way. We investigated the relationship between arterial stiffness and cytomegalovirus infection in
terms of T-cell senescence.
Methods and Results-—Arterial stiffness was evaluated using pulse wave velocity measurements in 415 Koreans (age
5912 years). We also investigated the frequency of CD57+ or CD28null senescent T cells in peripheral blood lymphocytes and
analyzed which immune parameters were correlated with pulse wave velocity. Furthermore, cytomegalovirus-speciﬁc T cells were
stimulated with overlapping peptides covering pp65 protein, and T-cell function was evaluated by intracellular cytokine staining of
interferon-c, tumor necrosis factor-a, and CD107a. In a multivariate analysis, it was found that the frequency of CD57+ cells in the
CD8+ T-cell subset was independently correlated with pulse wave velocity after adjusting for traditional cardiovascular risk factors
such as age, sex, diabetes mellitus history, smoking history, body mass index, blood pressure, serum creatinine, high-density
lipoprotein cholesterol, and high-sensitivity C-reactive protein. Cytomegalovirus pp65-speciﬁc T cells were more frequently
observed in the CD8+CD57+ population than in the CD8+CD57 population, and multivariate analysis revealed that the frequency
of cytomegalovirus pp65-speciﬁc interferon-c+, tumor necrosis factor-a+, or CD107a+ cells in the CD8+ T-cell subset was
independently correlated with pulse wave velocity as well.
Conclusions-—We demonstrate that arterial stiffness is associated with senescent CD57+ T cells and CMV pp65-speciﬁc T cells in
the CD8+ T-cell subset. The precise role of cytomegalovirus-speciﬁc, senescent T cells in vascular aging needs to be further
investigated. ( J Am Heart Assoc. 2017;6:e006535. DOI: 10.1161/JAHA.117.006535.)
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G rowing evidence from recent animal and human studiessuggests that T cells contribute to the development of
hypertension.1–4 Previously, we demonstrated that hyperten-
sive patients have an increased frequency of replicative
senescent CD8+ T cells in peripheral blood; these cells are
characterized by the loss of CD28 and the acquisition of CD57
on their surface.4 CD28 loss in T cells is one of the most
prominent changes associated with aging in humans and is
caused by the repetitive antigenic stimulation of T cells.5
CD57 expression is known to occur during the late stage of T-
cell differentiation and might be a distinct measure of
replicative senescence in T cells.6 Compared with CD28+ or
CD57 T cells, CD28null or CD57+ T cells produce more
proinﬂammatory cytokines and exert greater cytotoxicity.7
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ORIGINAL RESEARCH
These senescent T cells are known to be associated with
various inﬂammatory diseases in humans including cardio-
vascular disease.8–10
It has been also known that cytomegalovirus infection is
involved in the accumulation of CD28null or CD57+ senescent
T cells. In humans, cytomegalovirus is known to be one of the
most important antigens for repetitive T-cell stimulation,11
and latent infection with cytomegalovirus has been shown to
strongly exert age-associated changes on peripheral T cell
homeostasis.12 The cytomegalovirus-seropositive population
has a higher frequency of CD28null or CD57+, replicative
senescent T cells than the cytomegalovirus-seronegative
population.13 Moreover, cytomegalovirus infection is associ-
ated with a variety of chronic inﬂammatory processes in
cardiovascular disease14,15 such as hypertension.16 However,
it has not been elucidated how cytomegalovirus infection and
senescent T cells contribute to the pathogenesis of cardio-
vascular disease.
Increased arterial stiffness is one of the major mechanisms
underlying the pathogenesis of hypertension.17 Arterial stiff-
ness is increased in the presence of conventional cardiovas-
cular risk factors including aging.18,19 The degree of arterial
stiffness is known to be associated with various markers of
inﬂammation,20,21 suggesting that immune responses likely
play a role in increasing arterial stiffness. Furthermore, a
recent study has reported that activated T-cell markers are
associated with arterial stiffness among HIV-infected
patients.22 Therefore, we investigated whether T-cell senes-
cence is associated with arterial stiffness in the general
population, as assessed using pulse wave velocity (PWV)
measurements. Next, considering the antigen reactivity of
senescent T cells, we examined cytomegalovirus-speciﬁc
T-cell response and analyzed the relationship between these
results and the degree of arterial stiffness. Because increased
arterial stiffness is characteristic of the vascular aging
process, we attempted to elucidate the relationship between
vascular aging and T-cell aging.
Methods
Study Participants
The study population consisted of 415 Koreans who were
recruited from subjects initially registered in the Yonsei
Cardiovascular Genome cohort. They were recruited from the
outpatient clinic of Severance Cardiovascular Hospital irre-
spective of their disease status. The study population includes
those with hypertension, coronary artery disease, diabetes
mellitus (DM), and healthy subjects. The average age of the
cohort members was 59.411.7 years (20–82 years). Hyper-
tension was deﬁned as either a documented systolic blood
pressure of >140 mm Hg or a diastolic blood pressure of
>90 mm Hg over 3 visits before the use of antihypertensive
medication. DM was deﬁned as having fasting plasma glucose
levels >126 mg/dL, HbA1c >6.5%, or a history of DM therapy.
Coronary artery disease was deﬁned as 1 or more lesions with
a >50% diameter reduction either by invasive coronary
angiography or CT coronary angiography. At the time of
enrollment, patients underwent a complete physical exami-
nation and laboratory assessment. Peripheral blood pressure
was measured in both arms after 5 minutes of rest in a sitting
position using an OMRON HEM 780 device (OMRON Health-
care, Kyoto, Japan),23 and the higher values were used for the
analysis. Patients with any of the following conditions were
excluded from this study: signiﬁcant systemic disease,
malignant debilitating disease, severe hypertension (>200/
140 mm Hg), a history of overt chronic inﬂammatory disease
and/or were receiving anti-inﬂammatory medications. The
baseline clinical characteristics and laboratory data regarding
the study participants are summarized in Table 1. The
medications taken by the patients are summarized in
Table S1. All the measurements in this study including PWV
and the immunologic parameters were obtained while the
patients were taking their prescribed medications. This study
received prior approval from the Institutional Review Board of
the Yonsei University College of Medicine, and the procedures
followed were in accordance with institutional guidelines (IRB
number: 4-2001-0039, 4-2010-0500). All participants pro-
vided informed consent before enrollment.
PWV Measurements
PWV was measured as heart-femoral PWV using a VP-2000
pulse wave unit (Nippon Colin Ltd, Komaki City, Japan) as
previously described.24 The method was validated in 948
patients with hypertension or coronary artery disease by
Clinical Perspective
What Is New?
• Previously, immunologic mechanisms for arterial stiffening
have not been well addressed.
• This is the ﬁrst study to reveal the relationship between
cytomegalovirus-speciﬁc, senescent CD8+ T cells and
arterial stiffness in humans.
What Are the Clinical Implications?
• Cytomegalovirus-related T-cell aging may contribute to age-
associated arterial stiffness and hypertension.
• Future studies should address speciﬁc mechanisms by
which cytomegalovirus-speciﬁc, senescent T cells contribute
to arterial stiffening and therapeutic interventions to
prevent this process.
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showing high correlation and good agreement with the
conventional SphygmoCor system.25 Brieﬂy, carotid and
femoral artery pressure waveforms were recorded in multi-
element tonometry sensors at the left carotid and left femoral
arteries with patients in a supine position. The ECG was
monitored from electrodes placed on both wrists. Heart
sounds S1 and S2 were detected by placing a microphone on
the left edge of the sternum at the third intercostal space. The
waveform analyzer measured the time intervals between S2
and the notch of the carotid pulse wave (Thc) and between the
carotid and femoral artery pulse waves (Tcf). The sum of Thc
and Tcf represents the time required for pulse waves to travel
from the heart to the femoral artery (Thf). The heart-femoral
PWV, a marker of central aortic stiffness,26 was calculated as
Lhf/(Thc+Tcf), where Lhf is the distance from the heart to the
femoral artery. Lhf and the distance between the sampling
points were calculated based on patient height and then
divided by the time interval for the waveform from each
measuring point.
Immunophenotype Analysis of Peripheral Blood
Mononuclear Cells
Peripheral blood mononuclear cells from anticoagulated blood
were isolated using Ficoll-Hypaque (GE Healthcare, Uppsala,
Sweden) density gradient centrifugation. For surface staining,
peripheral blood mononuclear cells were incubated with
directly conjugated monoclonal antibodies for 20 minutes at
4°C. The antibodies used were anti-CD3 (horizon V500), anti-
CD4 (PE-Cy7), anti-CD8 (APC-H7), anti-CD19 (PerCP-Cy5.5),
anti-CD28 (APC) (all from BD Biosciences, San Jose, CA), and
anti-CD57 (eFluor 450) (Biolegend, San Diego, CA). Multicolor
ﬂow cytometry was performed using an LSR II instrument (BD
Biosciences), and FlowJo software (Treestar, San Carlos, CA)
was used to analyze the data.
In Vitro Stimulation of T Cells and Intracellular
Cytokine Staining
To analyze the speciﬁc antigen reactivity of T cells, peripheral
blood mononuclear cells were stimulated with overlapping
peptides from cytomegalovirus pp65 (0.6 nmol of each
peptide/mL; Miltenyi Biotec), which could directly bind to
MHC class I or II molecules on antigen-presenting cells and be
presented to CD8+ or CD4+ T cells in peripheral blood
mononuclear cell cultures, for 6 hours in the presence of
phycoerythrin (PE)-conjugated anti-CD107a (BD Biosciences).
The CD107a molecule is exposed to the cell surface during
degranulation of cytotoxic proteins such as perforin and
granzymes, and therefore PE-conjugated anti-CD107a was
added to the cultures for the detection of T cells with cytotoxic
activity.27,28 After 1 hour of incubation, brefeldin A (GolgiPlug,
BD Biosciences) and monensin (GolgiStop, BD Biosciences)
were added to accumulate cytokine protein intracellularly.
Following surface staining with anti-CD3 (horizon V500), anti-
CD4 (PerCP-Cy5.5), anti-CD8 (APC-H7), anti-CD28 (horizon
V450), and anti-CD57 (APC), the cells were ﬁxed and
permeabilized using a Fixation/Permeabilization Buffer Kit
and further stained for intracellular cytokines with anti-
interferon-c (IFN-c) (ﬂuorescein isothiocyanate conjugated)
and anti-tumor necrosis factor-a (TNF-a) (PE-Cy7) (both from
BD Biosciences). All samples were assessed using an LSR II
Flow Cytometer (BD Biosciences), and the data were analyzed
using FlowJo software (Treestar, San Carlos, CA). This assay
enables enumeration of cytomegalovirus pp65-speciﬁc T cells
in both T-cell compartments, CD8+ and CD4+ T cells.28,29
Measurement of Serum Anti-Cytomegalovirus IgG
Antibody Titers
Serum anti-cytomegalovirus immunoglobulin G (IgG) titers
were determined using a commercially available
Table 1. Baseline Characteristics of the Study Population
(n=415)
Age, y 59.411.7
Male sex 273 (65.8%)
CAD 281 (67.7%)
Hypertension 247 (59.5%)
DM 148 (35.7%)
Hyperlipidemia 179 (43.1%)
Current smoker 51 (12.3%)
BMI, kg/m2 25.23.1
SBP, mm Hg 131.317.1
DBP, mm Hg 80.811.0
Creatinine, mg/dL 1.00.7
Total cholesterol, mg/dL 163.141.1
HDL-cholesterol, mg/dL 48.211.9
LDL-cholesterol, mg/dL 88.134.7
Triglyceride, mg/dL 135.8122.2
hsCRP, mg/L 1.53.1
hfPWV, cm/s 1.016.6234.6
Frequency of T-cell subset, %
CD57+ cells in CD4+ T cells 6.16.0
CD28null cells in CD4+ T cells 4.45.7
CD57+ cells in CD8+ T cells 43.017.1
CD28null cells in CD8+ T cells 41.917.6
Data are presented as the meansSD or n (%). BMI indicates body mass index; CAD,
coronary artery disease; DBP, diastolic blood pressure; DM, diabetes mellitus; HDL,
high-density lipoprotein; hfPWV, heart-femoral pulse wave velocity; hsCRP, high-
sensitivity C-reactive protein; LDL, low-density lipoprotein; SBP, systolic blood pressure.
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chemiluminescent microparticle immunoassay (Abbott Labo-
ratories, Chicago, IL) in accordance with the manufacturer’s
instructions. A titer of 6.0 antibody units/mL of IgG or greater
was considered cytomegalovirus IgG-seropositive.
Statistical Analysis
Continuous variables are summarized as the meanSD.
Categorical variables are summarized as a percentage of the
group total. Continuous variables were compared using
Student t test and ANOVA. Intragroup comparisons were
summarized using the paired t test, and the Wilcoxon signed-
rank test was used to verify the results. Pearson’s correlation
analysis was used for the simple correlation between
continuous variables. To examine the association of senes-
cent T cells and cytomegalovirus-speciﬁc T-cell responses
with arterial stiffness, multiple linear regression models were
used, using heart-femoral PWV as the dependent variables
and the frequencies of senescent or cytomegalovirus-speciﬁc
T cells as the main independent variables of interest. All P
values were 2-sided and considered signiﬁcant at the 0.05
level. All statistical analyses were performed using SPSS 13.0
(SPSS Inc, Chicago, IL).
Results
The Frequency of CD8+CD57+ T Cells Is
Independently Correlated With Arterial Stiffness
In the present study, we investigated the signiﬁcance of T-cell
senescence in arterial stiffness. The study population con-
sisted of 415 Koreans who were registered in the Yonsei
Cardiovascular Genome cohort. The baseline characteristics
and laboratory data of the study participants are summarized
in Table 1. The mean frequencies of CD57+ and CD28null T
cells among the peripheral blood CD8+ T-cell population were
43.017.1% and 41.917.6%, respectively. In Figure 1A,
representative ﬂow cytometry plots are presented for CD57
and CD28 expression in the CD8+ T-cell subset from young
and old subjects. As expected, the frequency of CD57+
(r=0.410, P<0.001) or CD28null (r=0.391, P<0.001) cells
among the CD8+ T-cell subset was positively correlated with
age (Figure 1B). The study population showed a signiﬁcant,
positive relationship between age and systolic blood pressure
(Figure 1C). We analyzed the relationship between senescent
CD8+ T cells and blood pressure (Figure 1D) and found that
the frequency of CD8+CD57+ T cells was positively correlated
with systolic blood pressure (r=0.103, P=0.036). Next, we
analyzed the relationship between the frequency of senescent
T cells and PWV. The frequencies of CD8+CD57+ (r=0.322,
P<0.001) and CD8+CD28null (r=0.300, P<0.001) T cells were
both positively correlated with PWV (Figure 1E and 1F).
Because PWV is strongly affected by age and blood pressure,
we performed a multiple linear regression analysis of the
association between the frequency of senescent CD8+ T cells
and PWV after adjusting for traditional cardiovascular risk
factors including age, sex, systolic blood pressure, medical
history, and laboratory ﬁndings (Table 2). Based on this
analysis, the frequency of CD8+CD57+ T cells was indepen-
dently correlated with PWV (B=0.037, 95% conﬁdence interval
[CI], 0.001–0.073, P=0.047).
Cytomegalovirus pp65-Speciﬁc T Cells Are More
Frequently Observed in the CD57+ T-Cell
Population
Because amajor population within CD8+CD57+ T cells is known
to be reactive to cytomegalovirus,30 we analyzed cytomegalo-
virus-speciﬁc immune response parameters. First, cytomega-
lovirus serostatus was evaluated in a subgroup of 123
individuals, and all of these individuals were seropositive for
cytomegalovirus (data not shown). This result conﬁrms previous
reports showing high (96–98%) cytomegalovirus seropreva-
lence in Korean adults.31,32 Next, we investigated cytomega-
lovirus-speciﬁc T-cell responses by stimulating peripheral blood
mononuclear cells with overlapping peptides covering cytome-
galovirus pp65 protein in all 415 individuals. T-cell function was
evaluated using intracellular cytokine staining of IFN-c and TNF-
a. In addition, cytotoxic function of T cells was simultaneously
evaluated by CD107a staining, which measures the degranu-
lation of cytotoxic proteins such as perforin and granzymes.27
Figure 2A shows representative ﬂow cytometry plots for
cytomegalovirus pp65-speciﬁc IFN-c and TNF-a secretion and
CD107a staining in the CD8+ T-cell population against CD57
expression. Figure S1 shows the speciﬁcity of this assay by
representative ﬂow cytometry plots with or without stimulation
with cytomegalovirus pp65 overlapping peptides. As previously
found, cytomegalovirus pp65-speciﬁc T cells were more
frequent in the CD8+CD57+ population than in the CD8+CD57
population (Figure 2B), and the degree of cytomegalovirus
pp65-speciﬁc CD8+ T-cell responses was positively correlated
with increasing age (Figure 2C). Interestingly, cytomegalovirus
pp65-speciﬁcally IFN-c-producing cells represented >10% of
the CD8+CD57+ T-cell population in certain subjects (Fig-
ure 2B). We demonstrated that a major population of
CD8+CD57+ T cells was derived from cytomegalovirus infection
and that cytomegalovirus-speciﬁc CD8+ T cells are preferen-
tially present in the senescent CD57+ population.
Cytomegalovirus-Speciﬁc CD8+ T Cells Are
Independently Correlated With Arterial Stiffness
The relationship between cytomegalovirus pp65-speciﬁc CD8+
T-cell responses and the degree of arterial stiffness was
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assessed as well. The frequencies of cytomegalovirus pp65-
speciﬁc IFN-c and TNF-a secretion and CD107a staining in
CD8+ T cells were positively correlated with PWV (r=0.202,
P<0.001 for IFN-c; r=0.213, P<0.001 for TNF-a; and r=0.172,
P=0.001 for CD107a) (Figure 2D). We also performed multiple
linear regression analysis of the association between
cytomegalovirus pp65-speciﬁc CD8+ T-cell responses and
PWV after adjusting for traditional cardiovascular risk factors
(Table 3). The frequency of cytomegalovirus pp65-speciﬁc
IFN-c and TNF-a secretion and the cytotoxic function of CD8+
T cells were independently correlated with PWV (B=0.020,
95% CI, 0.007–0.033, P=0.003 for IFN-c; B=0.021, 95% CI,
0.006–0.036, P=0.006 for TNF-a; and B=0.033, 95% CI,
0.010–0.056, P=0.006 for CD107a).
Figure 1. The signiﬁcance of the frequency of senescent CD8+ T cells in blood pressure and PWV. Immunophenotyping of peripheral blood
mononuclear cells obtained from 415 individuals was performed. A, Representative ﬂow cytometry plots are presented for CD57 and CD28
expression in CD8+ T cells in a young (left) and an old subject (right). B, The frequency of CD57+ (gray) or CD28null (white) cells in CD8+ T cells is
plotted against age. C, Pearson’s correlation scatterplot of SBP and the age of all participants. D, Pearson’s correlation scatterplot of SBP and
the frequency of CD57+ (left) or CD28null (right) cells in CD8+ T cells. E and F, Pearson’s correlation presented by plotting hfPWV against the
frequency of CD57+ (E) or CD28null (F) cells in CD8+ T cells of the overall population. hfPWV indicates heart-femoral pulse wave velocity; PWV,
pulse wave velocity; SBP, systolic blood pressure.
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Anti-cytomegalovirus Humoral Immune Response
Is Not Correlated With Arterial Stiffness
Finally, we analyzed the relationship between the anti-
cytomegalovirus humoral immune response and arterial
stiffness. As described above, all individuals were positive
for anti-cytomegalovirus IgG antibody in a subgroup of 123
individuals. When we divided the individuals into 3 groups
according to anti-cytomegalovirus IgG antibody titer, no
signiﬁcant relationship was found between anti-cytomegalo-
virus IgG antibody titer and age (Figure 3A) or PWV
(Figure 3B). In addition, anti-cytomegalovirus IgG antibody
titer was not associated with the intensity of cytomegalovirus-
speciﬁc T-cell responses (Figure 3C). In summary, in view of
the immune response to cytomegalovirus, we found that
arterial stiffness is related only to T-cell-mediated immunity
and not to the humoral immune response against cytomega-
lovirus. Taken together, our data suggest that cytomegalo-
virus-speciﬁc, replicative senescent T cells, but not
cytomegalovirus-speciﬁc antibody, might contribute to
increased arterial stiffness in the general population.
Discussion
Our ﬁndings demonstrate that the frequency of senescent
CD8+CD57+ T cells in peripheral blood is independently
correlated with arterial stiffness. Cytomegalovirus-speciﬁc
T-cell responses were analyzed because cytomegalovirus is a
major driving antigen for replicative senescence in T cells.11
We found that cytomegalovirus-speciﬁc CD8+ T cells were
more frequently observed in the CD57+ population, and
cytomegalovirus-speciﬁc IFN-c and TNF-a-secretion and the
cytotoxic degranulation of CD8+ T cells were independently
associated with PWV. In the present study, we evaluated
cytomegalovirus pp65-speciﬁc T-cell activity not only by IFN-c
and TNF-a staining but also by CD107a staining. CD107a
molecule is exposed to the cell surface during degranulation
of cytotoxic proteins such as perforin and granzymes, and
therefore we can detect T cells with cytotoxic activity by
adding ﬂuorophore-conjugated anti-CD107a to the culture of
T cells during antigen stimulation.27,28 Our data showed that
the frequency of cytomegalovirus pp65-speciﬁc CD107a-
stained cells among CD8+ T cells was independently corre-
lated with PWV. These data suggest that immune aging,
especially T-cell senescence that is linked to cytomegalovirus
infection, might play a role in the progression of vascular
aging.
Recently, several research groups have reported the
existence and relevance of senescent T cells in various
cardiovascular diseases. In particular, the role of senescent T
cells in atherosclerotic disease has been extensively studied.
Accelerated telomere shortening in T cells and other leuko-
cyte subpopulations has been reported in patients with
coronary heart disease.33 It is not yet clear whether T cells
with shorter telomeres lead to increased cardiovascular risk
or telomere shortening in T cells is caused by the chronic
inﬂammation associated with cardiovascular disease. The
former explanation is more likely because proinﬂammatory
cytokines (such as interleukin-6 and TNF-a, which are
secreted by senescent T cells) are also found in atheroscle-
rotic plaque lesions.34 Other studies reported that increased
senescent memory CD4+ T cells are associated with subclin-
ical atherosclerosis, as assessed based on carotid artery
intimal media thickness and coronary artery calciﬁcation,35
particularly in patients with rheumatoid arthritis.36 In addition,
a higher frequency of CD8+CD28nullCD57+ T cells was found
to be correlated with an increased prevalence of carotid artery
Table 2. Multiple Linear Regression Analysis for
Determinants of PWV
Regression
Coefﬁcient 95% CI P Value
CD8+CD57+ T cells (R2=0.513)
Age, y 0.004 0.003 to 0.005 <0.001
Female sex 0.020 0.039 to 0.001 0.041
DM history 0.025 0.009 to 0.041 0.002
Smoking history 0.007 0.005 to 0.019 0.264
BMI, kg/m2 0.002 0.004 to 0.001 0.150
SBP, mm Hg 0.002 0.001 to 0.002 <0.001
Creatinine, mg/dL 0.004 0.006 to 0.015 0.409
HDL-cholesterol, mg/dL 0.000 0.001 to 0.000 0.576
hsCRP, mg/L 0.001 0.001 to 0.003 0.314
Percent CD57+
in CD8+ T cells*
0.037 0.001 to 0.073 0.047
CD8+CD28null T cells (R2=0.512)
Age, y 0.004 0.003 to 0.005 <0.001
Female sex 0.021 0.040 to 0.002 0.031
DM history 0.025 0.009 to 0.040 0.003
Smoking history 0.007 0.005 to 0.020 0.249
BMI, kg/m2 0.002 0.004 to 0.001 0.149
SBP, mm Hg 0.002 0.001 to 0.002 <0.001
Creatinine, mg/dL 0.005 0.006 to 0.015 0.404
HDL-cholesterol, mg/dL 0.000 0.001 to 0.000 0.576
hsCRP, mg/L 0.001 0.001 to 0.003 0.323
Percent CD28null
in CD8+ T cells*
0.029 0.004 to 0.062 0.086
BMI indicates body mass index; CI, conﬁdence interval; DM, diabetes mellitus; HDL, high-
density lipoprotein; hsCRP, high-sensitivity C-reactive protein; PWV, pulse wave velocity;
SBP, systolic blood pressure.
*Log-transformed.
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Figure 2. The signiﬁcance of cytomegalovirus pp65-speciﬁc CD8+ T-cell responses in the CD57+
population and PWV. Peripheral blood mononuclear cells were stimulated with cytomegalovirus pp65
overlapping peptides, and intracellular staining for IFN-c, TNF-a, and CD107a was performed. A,
Representative ﬂow cytometry plots are presented for IFN-c and TNF-a secretion and for CD107a
expression in the CD8+ T-cell populations. B, The frequencies of cytomegalovirus pp65-speciﬁc IFN-c-, TNF-
a-, and CD107a-expressing cells were compared between CD8+CD57+ and CD8+CD57 T-cell populations.
Cytomegalovirus pp65-speciﬁc responses were more frequently observed in CD8+CD57+ T cells than in the
CD8+CD57 population. The P value was calculated using the paired t test. C, Pearson’s correlation
presented as a scatterplot of age and the frequency of cytomegalovirus pp65-speciﬁc IFN-c-, TNF-a-, and
CD107a-expressing cells (log-transformed) in CD8+ T cells. D, Pearson’s correlation presented as a plot of
hfPWV against the frequency of cytomegalovirus pp65-speciﬁc IFN-c-, TNF-a-, and CD107a-expressing cells
(log-transformed) in CD8+ T cells of the overall population. hfPWV indicates heart-femoral pulse wave
velocity; IFN-c, interferon- c; TNF-a, tumor necrosis factor- a.
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lesions in a study of HIV-infected patients.37 Liuzzo et al38
reported that the number of CD4+CD28null T cells increased
signiﬁcantly in the peripheral blood of patients with unstable
angina. Furthermore, it was shown that increased frequency
of CD4+CD28null T cells was associated with the recurrence of
acute coronary events.39 Another study found that the
presence of CD4+CD28null T cells is correlated with the
occurrence of a ﬁrst cardiovascular event and with a worse
outcome after an acute coronary syndrome in diabetic
patients.40 More recently, a direct role of T cells in
hypertension has been demonstrated in angiotensin II-infused
humanized mice.41
Recent studies have suggested that cytomegalovirus
infection is associated with a variety of chronic inﬂammatory
processes in cardiovascular disease.14,15 An increase in the
number of peripheral CD8+CD57+ and CD8+CD28null T cells
has been reported in patients with coronary artery disease in
relation to cytomegalovirus infection.33,42 Cytomegalovirus-
speciﬁc T-cell responses have independently been associated
with carotid atherosclerosis in HIV-infected patients.43 In
terms of prognostic implications, the occurrence of cytome-
galovirus DNAemia is strongly associated with the death or
readmission of patients with acute heart failure.44 Further-
more, cytomegalovirus-seropositive subjects exhibiting high
C-reactive protein levels were at signiﬁcantly higher risk for
all-cause and cardiovascular disease–related mortality among
the general population.45 Cytomegalovirus infection has
effects beyond atherosclerotic disease; cytomegalovirus
caused a signiﬁcant increase in blood pressure that was
independent of atherosclerotic plaque formation in the aorta
in a mouse model.16 Moreover, recent research has shown
that cytomegalovirus seropositivity is independently associ-
ated with increased arterial stiffness in patients with chronic
kidney disease.46
Most studies on cytomegalovirus infection or on the
immune response to cytomegalovirus in humans have focused
on cytomegalovirus seroprevalence according to anti-cytome-
galovirus IgG antibody titers. However, the cytomegalovirus
seropositivity of nonwhites tends to be 20% to 30% higher
than that of whites, and some nonwhites, especially black and
Asian populations, exhibit cytomegalovirus seroprevalences
approaching 100%.47 This is also the case in Koreans.31,32
Among our study participants, the subgroup of 123 individuals
exhibited 100% cytomegalovirus seropositivity; therefore, we
were unable to analyze differences in the degree of arterial
stiffness according to cytomegalovirus seroprevalence.
Instead, we focused on cytomegalovirus-speciﬁc T cells and
found that the PWV is strongly correlated with the frequency
of cytomegalovirus-speciﬁc CD8+ T cells but is not correlated
with anti-cytomegalovirus IgG antibody titer. To the best of
our knowledge, this is the ﬁrst study to demonstrate an
independent correlation between cytomegalovirus-speciﬁc
Table 3. Multiple Linear Regression Analysis of the
Association Between Cytomegalovirus pp65-Speciﬁc CD8+ T
Cells and PWV
Regression
Coefﬁcient 95% CI P Value
Pp65-specific IFN-c secretion (R2=0.519)
Age, y 0.004 0.004 to 0.005 <0.001
Female sex 0.021 0.039 to 0.002 0.031
DM history 0.026 0.010 to 0.042 0.001
Smoking history 0.009 0.003 to 0.021 0.161
BMI, kg/m2 0.002 0.005 to 0.000 0.067
SBP, mm Hg 0.002 0.001 to 0.002 <0.001
Creatinine, mg/dL 0.003 0.008 to 0.014 0.579
HDL-cholesterol,
mg/dL
0.000 0.001 to 0.000 0.237
hsCRP, mg/L 0.001 0.001 to 0.003 0.361
Percent IFN-c+
in CD8+ T cells*
0.020 0.007 to 0.033 0.003
pp65-specific TNF-a secretion (R2=0.517)
Age, y 0.004 0.004 to 0.005 <0.001
Female sex 0.021 0.040 to 0.002 0.030
DM history 0.025 0.010 to 0.041 0.002
Smoking history 0.008 0.004 to 0.021 0.181
BMI, kg/m2 0.002 0.005 to 0.000 0.084
SBP, mm Hg 0.002 0.001 to 0.002 <0.001
Creatinine, mg/dL 0.004 0.007 to 0.015 0.453
HDL-cholesterol,
mg/dL
0.000 0.001 to 0.000 0.256
hsCRP, mg/L 0.001 0.001 to 0.003 0.351
Percent TNF-a+
in CD8+ T cells*
0.021 0.006 to 0.036 0.006
Pp65-specific CD107a expression (R2=0.517)
Age, y 0.004 0.003 to 0.005 <0.001
Female sex 0.021 0.040 to 0.002 0.027
DM history 0.027 0.011 to 0.043 0.001
Smoking history 0.009 0.004 to 0.021 0.174
BMI, kg/m2 0.002 0.004 to 0.000 0.116
SBP, mm Hg 0.002 0.001 to 0.002 <0.001
Creatinine, mg/dL 0.004 0.007 to 0.015 0.466
HDL-cholesterol,
mg/dL
0.000 0.001 to 0.000 0.330
hsCRP, mg/L 0.001 0.001 to 0.003 0.314
Percent CD107a+
in CD8+ T cells*
0.033 0.010 to 0.056 0.006
BMI indicates body mass index; CI, conﬁdence interval; DM, diabetes mellitus; HDL, high-
density lipoprotein; hsCRP, high-sensitivity C-reactive protein; IFN-c, interferon-c; PWV,
pulse wave velocity; SBP, systolic blood pressure; TNF-a, tumor necrosis factor-a.
*Log-transformed.
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CD8+ T-cell response and arterial stiffness. Considering the
correlation between cytomegalovirus-speciﬁc T cells and
arterial stiffness, it is hypothesized that cytomegalovirus-
speciﬁc T cells are more important than cytomegalovirus itself
during vascular pathogenesis in cytomegalovirus-seropositive
subjects.
The mechanism by which senescent T cells or cytomega-
lovirus-speciﬁc T cells contribute to vascular aging has not yet
been clearly identiﬁed. Considering the fact that senescent T
cells produce more proinﬂammatory cytokines than nonse-
nescent T cells,48 proinﬂammatory cytokines such as IFN-c
and TNF-a might injure vessel walls directly or activate other
immune cells. Indeed, senescent T cells have been shown to
produce large amounts of IFN-c that induce macrophage
activation, thereby releasing metalloproteinases that degrade
the extracellular matrix.49,50 Moreover, senescent T cells
exert higher cytotoxicity than nonsenescent T cells.51 In the
current study, arterial stiffness was independently correlated
with frequency of CD8+CD57+ T cells, but not with
CD4+CD57+ T cells. This result suggests that CD8+ T-cell
cytotoxicity might be a major effector function in increasing
arterial stiffness. Homing properties of T cells need to be
considered in T-cell-mediated vascular injury. Bolovan-Fritts
et al52 revealed that cytomegalovirus-reactive T cells induce
endothelial damage via fractalkine-CX3C motif chemokine
receptor 1 (CX3CR1) interaction. We previously conﬁrmed
that CD8+CD57+ T cells express higher levels of CX3CR1,53
suggesting that these senescent T cells might participate in
endothelial dysfunction progression.
The present study has limitations. First, this is a human
observational study, rather than an interventional study.
Therefore, it is difﬁcult to identify a direct cause-and-effect
relationship. Even though the statistical methods of multi-
variate analysis in the current study are clear and sound, the
principal correlations are relatively weak with limited explana-
tory power. However, the results of multivariate analysis are
not a ﬁnal outcome in itself, but rather serve as a bridgehead
for the pathophysiologic evaluation of arterial stiffening in
terms of cytomegalovirus infection. Future studies are
required to address speciﬁc mechanisms by which cytome-
galovirus-speciﬁc, senescent T cells contribute to arterial
stiffening. Second, we could not use live/dead cell staining in
the ﬂow cytometry analysis because of a limitation in the
multicolor staining panel. However, we have conﬁrmed that
Figure 3. Anti-cytomegalovirus IgG titer is not correlated with age, PWV, or cytomegalovirus pp65-speciﬁc CD8+ T-cell responses. Serum anti-
cytomegalovirus IgG antibody titer was assessed in a subgroup of 123 individuals. The population was divided into 3 groups according to
antibody titer (<150, 150–250, and >250 AU/mL). Age (A), hfPWV (B), and cytomegalovirus pp65-speciﬁc CD8+ T-cell responses (C) were
comparable among the 3 groups. A P<0.05 was considered signiﬁcant (ANOVA). AU indicates antibody units; CMV, cytomegalovirus; hfPWV,
heart-femoral pulse wave velocity; IFN-c, interferon- c; IgG, immunoglobulin G; ns, not signiﬁcant; TNF-a, tumor necrosis factor-a.
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autoﬂuorescence from dead cells in our analysis was minimal
and almost negligible based on our previous experiments.
Conclusion
Arterial stiffness is associated with CD8+CD57+ T cells and
cytomegalovirus-speciﬁc IFN-c and TNF-a-secretion and with
the cytotoxic degranulation of CD8+ T cells. These ﬁndings
might provide a new perspective on the immune-related
mechanism of arterial stiffness and might lead to a new
therapeutic strategy for arresting the progression of human
hypertension. The precise role of these CD8+CD57+ T cells
and cytomegalovirus-speciﬁc CD8+ T-cell responses warrants
further investigation.
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SUPPLEMENTAL MATERIAL 
Table S1. Summary of the medications taken by the study population (n=415)  
Types of medication N (%) 
Antihypertensive 293 (70.6%) 
Hypoglycemic 67 (16.1%) 
Lipid-lowering 272 (65.5%) 
Antiplatelet 262 (63.1%) 
Anticoagulation 66 (15.9%) 
Antiarrhythmic 56 (13.5%) 
Figure S1. Representative flow cytometry plots are presented for IFN-γ and TNF-α secretion 
and for CD107a staining in the CD8+ T cell populations with or without stimulation with CMV 
pp65 overlapping peptides.  
 
 
 
